Today: 7 February 2026
Subscribe
Browse Category

NYSE:MCK News 4 December 2025 - 6 February 2026

McKesson stock falls today after 16% earnings surge as traders reassess guidance and spinoff clock (MCK)

McKesson stock falls today after 16% earnings surge as traders reassess guidance and spinoff clock (MCK)

McKesson shares fell 2.1% to $937.31 Friday, retreating after a 16.5% surge on an upgraded 2026 profit forecast and plans to spin off its medical-surgical division. Quarterly revenue rose 11% to $106.2 billion, with adjusted EPS up 16% to $9.34. The company filed an automatic shelf registration for future securities sales. TD Cowen raised its price target to $1,012, citing strong oncology and prescription-tech results.
6 February 2026
··
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.
5 February 2026
····
McKesson Stock (MCK) After-Hours Update for Dec. 24, 2025: Today’s News, Analyst Forecasts, and What to Watch Before the Market Reopens Dec. 26

McKesson Stock (MCK) After-Hours Update for Dec. 24, 2025: Today’s News, Analyst Forecasts, and What to Watch Before the Market Reopens Dec. 26

McKesson Corporation (NYSE: MCK) ended the Christmas Eve session essentially flat, then edged slightly lower in thin after-hours trading—an unsurprising setup for a holiday-shortened day when liquidity typically dries up and price moves can be noisy. Here’s what happened after the bell on Wednesday, December 24, 2025, what the latest forecasts and analyst takes are saying today, and what investors may want on their radar before the U.S. stock market’s next regular session on Friday, December 26, 2025. Nasdaq McKesson stock after the bell: the key numbers (Dec. 24, 2025) McKesson shares closed at $826.43, up $0.71 (+0.09%) in the
25 December 2025
·
Shops Open on Christmas Day 2025 in Canada: What’s Open, What’s Closed, and Where to Find Essentials

Shops Open on Christmas Day 2025 in Canada: What’s Open, What’s Closed, and Where to Find Essentials

Updated: Wednesday, December 24, 2025 (Christmas Day is Thursday, Dec. 25) Christmas Day in Canada is a statutory holiday, which means most retailers go dark—malls lock up, big-box stores turn off the lights, and even many grocery aisles are quiet. Time and Date But last-minute needs don’t take the day off. Whether it’s cold medicine, diapers, a phone charger, or a missing ingredient for dinner, Canadians still look for a handful of reliable places that tend to stay open on December 25. Based on current local holiday-hours coverage published during the Dec. 24–25 news cycle—plus official retailer schedules—here’s where you can still
25 December 2025
······
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) McKesson Corporation (NYSE: MCK) ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high ($895.58 on Nov. 26), but it remains one of healthcare’s stronger large-cap performers in 2025 as investors continue to reward its specialty-drug and oncology momentum, capital returns, and portfolio reshaping narrative. MarketWatch+1 Below is a detailed recap of what moved McKesson stock this week, the latest company and analyst developments, and the key catalysts traders are watching in the week ahead.
13 December 2025
·
McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (NYSE: MCK) is ending 2025 as one of the standout performers in U.S. healthcare — but as of Wednesday, December 3, its stock is taking a breather. At the close, McKesson shares finished at $805.37, down 2.93% on the day and roughly 10% below their recent 52‑week high near $895, even after a powerful rally through most of the year.Wallstrank+2MarketWatch+2 Behind that pullback is a mix of profit‑taking after record highs, institutional portfolio shuffling, and investors digesting a wave of new guidance, long‑term targets, oncology initiatives and valuation debates. This article walks through: Key Takeaways on McKesson Stock
4 December 2025
·

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop